
Education and Training
- Fellowship in Cardiology, Medicine, Duke University School of Medicine, 1997 - 2001
- Residency in Internal Medicine, Medicine, Brigham and Women's Hospital, 1994 - 1997
- M.D., Harvard Medical School, 1994
Zdradzinski, M., R. Elkin, S. Flamm, and R. Krasuski. “Incremenal Value of Cardiac Magnetic Resonance for Assessing Pulmonic Valve Regurgitation.” The Journal of Heart Valve Disease 24, no. 4 (July 1, 2015): 502–7.
Zdradzinski, Michael, Rachel Elkin, Scott Flamm, and Richard Krasuski. “Incremenal Value of Cardiac Magnetic Resonance for Assessing Pulmonic Valve Regurgitation..” J Heart Valve Dis 24, no. 4 (July 2015): 502–7.
Abernethy, Abraham D., Kathryn Stackhouse, Stephen Hart, Ganesh Devendra, Thomas M. Bashore, Raed Dweik, and Richard A. Krasuski. “Impact of diabetes in patients with pulmonary hypertension..” Pulm Circ 5, no. 1 (March 2015): 117–23. https://doi.org/10.1086/679705.
Zdradzinski, Michael John, Abraham Abernethy, Rachel Elkin, Kathryn Stackhouse, Mohammed Halane, Wael ElMallah, and Richard Krasuski. “IMPACT OF PULMONARY HYPERTENSION ON RIGHT HEART REMODELING FOLLOWING DEVICE CLOSURE OF ATRIAL SEPTAL DEFECTS.” In Journal of the American College of Cardiology, 65:A571–A571. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60571-x.
Zdradzinski, Michael, Abraham Abernethy, Kathryn Stackhouse, Rachel Elkin, Mohamed Halane, Wael ElMallah, and Richard Krasuski. “IMPACT OF PERSISTENT RIGHT TO LEFT SHUNT IN DEVICE-OCCLUDED ATRIAL SEPTAL DEFECTS.” In Journal of the American College of Cardiology, 65:A569–A569. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60569-1.
Elkin, Rachel, and Richard A. Krasuski. “Therapy and clinical trials..” Curr Opin Lipidol 26, no. 1 (February 2015): 70–71. https://doi.org/10.1097/MOL.0000000000000151.
Zdradzinski, M., R. Elkin, S. Hart, S. Flamm, and R. Krasuski. “Incremental value of cardiac magnetic resonance for assessing pulmonic valve regurgitation.” Journal of Heart Valve Disease 24, no. 4 (January 1, 2015).
Chongthammakun, Vasutakarn, and Richard A. Krasuski. “Therapy and clinical trials..” Curr Opin Lipidol 25, no. 5 (October 2014): 410–11. https://doi.org/10.1097/MOL.0000000000000116.
Stackhouse, K., N. Sodhi, V. Gupta, O. Minai, R. Dweik, and R. A. Krasuski. “Impact of early initiation of intravenous prostanoid therapy in patients with congenital heart disease-related pulmonary arterial hypertension.” In European Heart Journal, 35:237–38. OXFORD UNIV PRESS, 2014.
Stackhouse, K., J. Jacob, and R. A. Krasuski. “Impact of insurance status on survival in pulmonary hypertension.” In European Heart Journal, 35:72–72. OXFORD UNIV PRESS, 2014.